325 related articles for article (PubMed ID: 8551620)
1. The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor?
Bour S; Schubert U; Peden K; Strebel K
J Virol; 1996 Feb; 70(2):820-9. PubMed ID: 8551620
[TBL] [Abstract][Full Text] [Related]
2. The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses.
Bour S; Strebel K
J Virol; 1996 Dec; 70(12):8285-300. PubMed ID: 8970948
[TBL] [Abstract][Full Text] [Related]
3. Influence of human immunodeficiency virus type 1 envelope glycoprotein YXXL endocytosis/polarization signal on viral accessory protein functions.
Cervantes-Acosta G; Lodge R; Lemay G; Cohen EA
J Hum Virol; 2001; 4(5):249-59. PubMed ID: 11907382
[TBL] [Abstract][Full Text] [Related]
4. The HIV-1 Vpu protein: a multifunctional enhancer of viral particle release.
Bour S; Strebel K
Microbes Infect; 2003 Sep; 5(11):1029-39. PubMed ID: 12941395
[TBL] [Abstract][Full Text] [Related]
5. gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.
D'Aloja P; Olivetta E; Bona R; Nappi F; Pedacchia D; Pugliese K; Ferrari G; Verani P; Federico M
J Virol; 1998 May; 72(5):4308-19. PubMed ID: 9557721
[TBL] [Abstract][Full Text] [Related]
6. HIV accessory proteins: leading roles for the supporting cast.
Trono D
Cell; 1995 Jul; 82(2):189-92. PubMed ID: 7628010
[No Abstract] [Full Text] [Related]
7. HIV accessory proteins as therapeutic targets.
Miller RH; Sarver N
Nat Med; 1997 Apr; 3(4):389-94. PubMed ID: 9095171
[No Abstract] [Full Text] [Related]
8. Role of viral regulatory and accessory proteins in HIV-1 replication.
Seelamgari A; Maddukuri A; Berro R; de la Fuente C; Kehn K; Deng L; Dadgar S; Bottazzi ME; Ghedin E; Pumfery A; Kashanchi F
Front Biosci; 2004 Sep; 9():2388-413. PubMed ID: 15353294
[TBL] [Abstract][Full Text] [Related]
9. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs.
Arrigo SJ; Chen IS
Genes Dev; 1991 May; 5(5):808-19. PubMed ID: 1827422
[TBL] [Abstract][Full Text] [Related]
10. Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx.
Wu X; Liu H; Xiao H; Kim J; Seshaiah P; Natsoulis G; Boeke JD; Hahn BH; Kappes JC
J Virol; 1995 Jun; 69(6):3389-98. PubMed ID: 7745685
[TBL] [Abstract][Full Text] [Related]
11. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains.
Schubert U; Bour S; Ferrer-Montiel AV; Montal M; Maldarell F; Strebel K
J Virol; 1996 Feb; 70(2):809-19. PubMed ID: 8551619
[TBL] [Abstract][Full Text] [Related]
12. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
Wu X; Liu H; Xiao H; Kappes JC
Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 Vpu accessory protein induces caspase-mediated cleavage of IRF3 transcription factor.
Park SY; Waheed AA; Zhang ZR; Freed EO; Bonifacino JS
J Biol Chem; 2014 Dec; 289(51):35102-10. PubMed ID: 25352594
[TBL] [Abstract][Full Text] [Related]
14. Vpu exerts a positive effect on HIV-1 infectivity by down-modulating CD4 receptor molecules at the surface of HIV-1-producing cells.
Levesque K; Zhao YS; Cohen EA
J Biol Chem; 2003 Jul; 278(30):28346-53. PubMed ID: 12746459
[TBL] [Abstract][Full Text] [Related]
15. The Vif and Vpr accessory proteins independently cause HIV-1-induced T cell cytopathicity and cell cycle arrest.
Sakai K; Dimas J; Lenardo MJ
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3369-74. PubMed ID: 16492778
[TBL] [Abstract][Full Text] [Related]
16. Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env.
Schubert U; Bour S; Willey RL; Strebel K
J Virol; 1999 Feb; 73(2):887-96. PubMed ID: 9882289
[TBL] [Abstract][Full Text] [Related]
17. Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice.
Aldrovandi GM; Zack JA
J Virol; 1996 Mar; 70(3):1505-11. PubMed ID: 8627668
[TBL] [Abstract][Full Text] [Related]
18. The HIV-1 matrix domain of Gag is required for Vpu responsiveness during particle release.
Lee YH; Schwartz MD; Panganiban AT
Virology; 1997 Oct; 237(1):46-55. PubMed ID: 9344906
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of a novel DNA vaccine cassette expressing multiple human immunodeficiency virus (HIV-1) accessory genes.
Ayyavoo V; Kudchodkar S; Ramanathan MP; Le P; Muthumani K; Megalai NM; Dentchev T; Santiago-Barrios L; Mrinalini C; Weiner DB
AIDS; 2000 Jan; 14(1):1-9. PubMed ID: 10714562
[TBL] [Abstract][Full Text] [Related]
20. Envelope glycoprotein and CD4 independence of vpu-facilitated human immunodeficiency virus type 1 capsid export.
Yao XJ; Göttlinger H; Haseltine WA; Cohen EA
J Virol; 1992 Aug; 66(8):5119-26. PubMed ID: 1629967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
